← Eichor
Study identifier: NCT05960968 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Gender Specific Registry in Subjects Hospitalized With Heart Failure in Santiago

Condition: Heart Failure  ·  Sponsor: Fundacion de la Sociedad Chilena de Cardiologia y Cirugia Cardiovascular

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is an observational registry, which main purpose is to assess sex-related differences in heart failure (HF) presentation, management, and prognosis in patients admitted to a hospital with a certain diagnosis of HF. The diagnosis will be based on European Society of Cardiology (ESC) definition of HF ( clinical syndrome characterized by symptoms and/or signs caused by a cardiac abnormality, that results in elevated intracardiac pressure and/or inadequate output at rest or exercise ). The sample will be obtained prospectively by recruitment of patients of two hospitals of Santiago de Chile.

This description comes directly from the study's public registry record.

Talk to the study team

PAOLA VARLETA, MD  ·  +569 95390767  ·  pao.varleta@gmail.com

MONICA ACEVEDO, MD  ·  +569 92282617  ·  macevedo@ucchristus.cl

Always discuss trial participation with your own doctor first.

Locations (1)

Paola VarletaSantiago, Santiago Metropolitan, ChileRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05960968